Recent Advances in Autoimmune Rheumatic Diseases—3rd Edition
A special issue of Medicina (ISSN 1648-9144). This special issue belongs to the section "Hematology and Immunology".
Deadline for manuscript submissions: 30 April 2026 | Viewed by 110
Special Issue Editor
Interests: autoimmunity; Sjogren’s disease; non-autoimmune/autoimmune epithelitis; sicca syndrome; saliva; microbiota; personalized medicine
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Autoimmune rheumatic diseases represent the leading cause of disability worldwide, with major financial and social consequences across cultures. The number of people suffering from them is increasing, especially in more economically developed countries. Autoimmune rheumatic diseases comprise a group of diseases characterised by heterogeneous clinical, laboratory, and immunological manifestations. Their pathogenesis is not fully understood, but recent research recognises that the pathogenesis of autoimmune rheumatic diseases is multifactorial, emphasizing the need for patient-centred collaboration between clinicians and researchers.
This Special Issue will focus on the latest advances in autoimmune rheumatic diseases, with the aim of significantly contributing to clinical practice, improving public health, and sharing up-to-date information on the latest advances in autoimmune rheumatic diseases. We invite you to submit your original research and review articles to this Special Issue.
Dr. Diana Mieliauskaitė
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Medicina is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- autoimmune rheumatic diseases
- rheumatoid arthritis
- systemic lupus erythematosus
- Sjogren’s disease
- systemic scleroderma
- psoriatic arthritis
- mixed connective tissue disease
- ankylosing spondylitis
- vasculitides
- juvenile arthritis
- rare autoimmune rheumatic diseases
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.
Further information on MDPI's Special Issue policies can be found here.
